MHRA approves Linerixibat (Lynavoy) for the treatment of itch due to biliary tract disease
The Medicines and Healthcare products Regulatory Agency (MHRA) has today 1 May 2026, approved Linerixibat (Lynavoy) for use to treat an itch in adults…